Recent Finacing
Recent Raise
Pionyr Immunotherapeutics develops antibody therapeutics using a Myeloid Tuning platform and target discovery and antibody-generation tools to rebalance tumor myeloid infiltrates and advance programs to IND for solid tumors.
